Literature DB >> 21170543

Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience.

Mine Kanat-Pektas1, Mustafa Ozat, Tayfun Gungor, Türkan Dikici, Bulent Yilmaz, Leyla Mollamahmutoglu.   

Abstract

OBJECTIVE: The present study aims to document the experience of a single center on the reproductive outcome of a cohort of women who were treated with conservative surgery for borderline ovarian tumors and to specify whether their fertility potential is associated with age, tumor histology and surgery type.
METHODS: A total of 55 women who had undergone conservative surgery for borderline ovarian tumors between January 1999 and January 2009 were eligible. Recurrence rate, fertility outcome and the number of pregnancies were analyzed retrospectively.
RESULTS: Among the study group, 11 women were not sexually active both at the time of surgery and during the follow-up period. Thus, a total of 44 patients attempted pregnancy after conservative surgery and 52.3% of them (23 out of 44) were able to conceive either spontaneously or by in vitro fertilization. The ability to conceive was shown to be associated with age, tumor histology and type of conservative surgery. As expected, the fertility potential correlated positively with decreasing age (correlation coefficient = 0.705, p = 0.001). Moreover, the existence of non-serous histology and the implementation of unilateral cystectomy were found to be associated with the ability to reach a clinical pregnancy (correlation coefficient = 0.585, p = 0.001 and correlation coefficient = 0.587, p = 0.001, respectively).
CONCLUSIONS: The primary treatment of borderline ovarian tumors refers to conservative surgery. Younger age, non-serous histology and unilateral cystectomy appear to be associated with favorable reproductive outcome in women who undergo conservative surgery for borderline malignancy of ovary.

Entities:  

Mesh:

Year:  2010        PMID: 21170543     DOI: 10.1007/s00404-010-1804-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.

Authors:  Na Li; Xiu Ming; Zhengyu Li
Journal:  Arch Gynecol Obstet       Date:  2020-08-03       Impact factor: 2.344

2.  Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.

Authors:  Tayfun Güngör; Metin Kaba; Eralp Başer; Hakan Yalçın; Hatice Bayramoğlu; Mustafa Beşli
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

Review 3.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

4.  Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.

Authors:  Rui-Fang Chen; Jun Li; Ting-Ting Zhu; Hai-Lin Yu; Xin Lu
Journal:  J Ovarian Res       Date:  2016-03-18       Impact factor: 4.234

5.  Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary.

Authors:  Shuang-Zheng Jia; Jun-Ji Zhang; Jun-Jun Yang; Yang Xiang; Zhiyong Liang; Jin-Hua Leng
Journal:  J Ovarian Res       Date:  2018-04-19       Impact factor: 4.234

6.  Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.

Authors:  Peng Wang; Lei Fang
Journal:  World J Surg Oncol       Date:  2021-04-21       Impact factor: 2.754

7.  Borderline ovarian tumors: a study of 100 cases from a Tertiary Care Hospital.

Authors:  Ahmet Uysal; Semih Mun; Fatma Uysal; Murat Oztekin; Cem Büyüktosun; Salim Sehirali; Omer Başoğul; Cüneyt E Taner
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28

8.  Surgical approach to giant ovarian masses in adolescents: technical considerations.

Authors:  Giorgio Persano; Elisa Severi; Noemi Cantone; Filippo Incerti; Enrico Ciardini; Bruno Noccioli
Journal:  Pediatr Rep       Date:  2018-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.